US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Sight Sciences, Inc. - Common Stock
(NQ:
SGHT
)
8.530
-0.500 (-5.54%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sight Sciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
IPO Preview: F45 Training, SoHo House Owner Among 8 IPOS To Watch This Week
↗
July 14, 2021
After a shortened holiday week, the IPO market is heating back up with some big names filing to go public and the debut of many companies. Here is a look at some of the...
Via
Benzinga
Topics
Initial Public Offering
Ocular Medical Device Firm Sight Sciences Sets Terms For $150M IPO
↗
July 09, 2021
Ophthalmic device developer Sight Sciences (NASDAQ: SGHT) hopes to see its way to nearly a $1 billion valuation through a $150 million Nasdaq debut. The IPO includes 7...
Via
Benzinga
Topics
Initial Public Offering
< Previous
1
2
3
4
5
6
7
Next >